Abstract:
The present disclosure relates to polypeptides, including fusions thereof, nucleic acids, vectors, host cells, immunodiagnostic reagents, kits, and immunoassays for use detecting the presence of HCV antibodies. More specifically, the present invention describes specific NS3 antigens that can be used for the detection of anti-HCV antibodies.
Abstract:
Monoclonal antibodies for the detection of Hepatitis C Virus (HCV) antigen are provided. The antibodies specifically immunoreactive with at least one epitope of the lipid binding domain of amino acid residues 134-171 of HCV core antigen. Immunoassay methods of using antibodies, kits and compositions comprising the antibodies for detecting HCV infection are further provided.